Overview
Headquarters
Grand Prairie, Texas
Category
Precision Oncology
We believe in delivering precision oncology to patients and physicians, empowering them with clear answers—and peace of mind—about their treatment management path. Agendia is a leading precision oncology company that brings cutting-edge genomics research into routine clinical practice. Our MammaPrint and BluePrint tests help physicians with complex treatment management decisions for women with early-stage breast cancer, delivering added insight from the individual genomic signature of their patient's tumor. We are committed to pursuing the best science, which has been validated through our collaborations with leading cancer centers, academic groups and pharmaceutical companies, in the form of landmark trials such as MINDACT, and the ongoing ISPY-2 trial, and our FLEX and PRECiSE Big Data studies. Amplex Corporation provides turnkey solutions. The Company offers call center with multiple toll-free lines for product kitting, warehousing, and shipping, as well as customer services. Amplex serves clients in the State of Texas. Headquartered outside Dallas, Texas, Amplex Corporation is a national leader in providing turnkey services for product kitting, packaging and fulfillment, as well as warehousing and global shipping. We provide dedicated expertise and superior service to a variety of small businesses all the way to several Fortune 500 clients across the country. With a secured warehouse facility, fully-staffed on-site call center, and multiple assembly lines capable of handling short run orders all the way to tens of thousands of products per day, Amplex Corporation is the simple solution to all your product fulfillment needs. Visit online at www.Amplex.com for more information. We were founded in 2003 as a spin-off from the Netherlands Cancer Institute / Antoni van Leeuwenhoek Hospital in Amsterdam, for the purpose of pursuing commercialization of molecular diagnostics using DNA microarray technology for cancer diagnosis and drug development. In 2004, we launched the initial version of our MammaPrint® breast cancer recurrence test in Europe.In 2006, we subjected MammaPrint to an international independent retrospective validation which led to the selection of MammaPrint as the exclusive molecular diagnostic stratification tool for the MINDACT trial, featuring 6,600 patients at 109 institutions in nine European countries.In 2007, MammaPrint became the first IVDMIA to obtain 510(k) clearance from the FDA, and after receipt of the regulatory clearance, we made MammaPrint commercially available in the United States in 2008. Since 2007, MammaPrint has received an additional four FDA clearances. Agendia, Inc. is located in Irvine, CA, United States and is part of the Mental Health & Substance Abuse Services Industry. Agendia, Inc. has 107 total employees across all of its locations and generates $18.74 million in sales (USD). There are 2 companies in the Agendia, Inc. corporate family. Agendia, Inc. is located in Irvine, CA, United States and is part of the Mental Health & Substance Abuse Services Industry. Agendia, Inc. has 107 total employees across all of its locations and generates $18.74 million in sales (USD). There are 2 companies in the Agendia, Inc. corporate family.
